Benzotriazonine as a new core structure for the design of CCK-receptor antagonists
β Scribed by Achim Escherich; Chantal Escrieut; Daniel Fourmy; Luis Moroder
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 68 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1075-2617
No coin nor oath required. For personal study only.
β¦ Synopsis
The search for heterocyclic scaffolds for the design of non-peptidic and highly selective agonists or antagonists of peptide hormone receptors led to 4-N-benzyl-2,3,4,5,6,7-hexahydro-1H-1,4,7-benzotriazonin-2,6-dione with a 9-membered core structure as a new low mass lead compound that exhibits submicromolar antagonistic activity at the CCK-A receptor with a 54-fold selectivity over the CCK-B/gastrin receptor.
π SIMILAR VOLUMES
Stabilization of biologically active conformations of native peptides by cyclization or introduction of hindering residues led to peptidominetics endowed with high affinity and selectivity for one class of receptors and able to cross the blood brain barrier. This is the case of BUBU, Tyr-D-Ser( OtBu